<DOC>
	<DOCNO>NCT00882609</DOCNO>
	<brief_summary>The primary objective compare diagnostic performance 18F- Fluoride PET/CT scan conventional bone scan detect cancer spread bone ( bone metastasis ) . The intent study determine whether 18F-Fluoride PET/CT lead improve treatment patient outcome .</brief_summary>
	<brief_title>F18PET/CT Versus TC-MDP Scanning Detect Bone Mets</brief_title>
	<detailed_description>The trial accrue four hundred-eighty eight ( 488 ) evaluable patient breast cancer , prostate cancer lung cancer ( approximately 163 cancer type ) refer routine bone scan respective physician . The specific stage cancer require eligibility describe eligibility criterion . Approximately eleven fifteen qualify clinical center participate trial , target enrollment site set roughly 40-50 patient per site . The image patient transmit ACR Image Metrix , image contract research organization ( iCRO ) , quality assurance archival . iCRO conduct blind core lab interpretation 3 radiologist involve design trial clinical image interpretation . The data core lab reading compare deliberation multidisciplinary panel oncology expert blind initial scan result determine standard evidence ( truth ) patient . The analysis base comparison .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<mesh_term>Sodium Fluoride</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<mesh_term>Listerine</mesh_term>
	<criteria>Patient ≥ 18 year old time drug administration ( Patient may male female race / ethnicity . ) Patient patient 's legally acceptable representative cognitively provide write informed consent Patients without know bone metastases newly diagnose ≥ stage 3 breast cancer , ≥ stage 3 lung cancer , ≥ stage 2 prostate cancer ( and/or PSA &gt; 10 micrograms/L ) , include patient recurrent breast , lung prostate cancer Patient schedule undergo conventional bone scan Patient capable comply study procedure Patient able remain still duration image procedure ( one hour ) Patient may prior PET PET/CT scan staging/restaging . Patient &lt; 18 year old time drug administration Patient pregnant nursing ; test site institution ( urine serum ßHCG ) within 24 hour prior start investigational product administration obtain surgical history ( e.g. , tubal ligation hysterectomy ) confirm subject post menopausal , minimum 1 year without menses Patient condition personal circumstance , judgment investigator , might interfere collection complete good quality data Patient known bone metastasis Patient previously receive [ 18F ] NaF last thirty day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>bone metastasis</keyword>
	<keyword>bone metastasis</keyword>
	<keyword>Sodium Fluoride</keyword>
	<keyword>F18 Fluoride</keyword>
	<keyword>bone scan</keyword>
</DOC>